June 5, 2018
The Japan Pharmaceutical Manufacturers Association’s (JPMA) Office of Pharmaceutical Industry Research (OPIR), a unit that analyzes the environments of the industry and the mid- to long-term issues it faces, has issued its FY2017 annual report on the use of big...read more